Voyager Digital (VYGVF) – Declaration of CEO Stephen Ehrlich

Thursday, July 07, 2022

Voyager Digital (VYGVF)
Declaration of CEO Stephen Ehrlich

Voyager Digital Ltd.’s (TSX: VOYG) (OTCQX: VYGVF) (FRA: UCD2) US subsidiary, Voyager Digital, LLC, is a fast-growing cryptocurrency platform in the United States founded in 2018 to bring choice, transparency, and cost-efficiency to the marketplace. Voyager offers a secure way to trade over 100 different crypto assets using its easy-to-use mobile application. Through its subsidiary Coinify ApS, Voyager provides crypto payment solutions for both consumers and merchants around the globe. To learn more about the company, please visit https://www.investvoyager.com.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Joshua Zoepfel, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

First Day. We spent yesterday going through Voyager Digital’s Chapter 11 petitions and first day motions. The filings provide an overview of recent events behind the Chapter 11 filing, the current state of the Company, and the Company’s efforts to reorganize, both prior to the Chapter 11 filing and its plans for a standalone restructuring.

The Cliff Note. According to the Declaration of Voyager CEO Stephen Ehrlich, Voyager faced a short-term “run on the bank” due to the downturn in the cryptocurrency industry generally and the default of the 3AC loan. Ultimately, Voyager filed for chapter 11 relief to protect customers and preserve the value of the business….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Axcella Therapeutics (AXLA) – Long COVID Enrollment Completed; OHE Trial Suspended

Tuesday, May 31, 2022

Axcella Therapeutics (AXLA)
Long COVID Enrollment Completed; OHE Trial Suspended

Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). The company’s product candidates are comprised of EMMs and derivatives that are engineered in distinct combinations and ratios to restore cellular homeostasis in multiple key biological pathways and improve cellular energetic efficiency. Axcella’s pipeline includes lead therapeutic candidates in Phase 2 development for the treatment of Long COVID and non-alcoholic steatohepatitis (NASH), and the reduction in risk of overt hepatic encephalopathy (OHE) recurrence. The company’s unique model allows for the evaluation of its EMM compositions through non-IND clinical studies or IND clinical trials. For more information, please visit www.axcellatx.com.

Robert LeBoyer, Vice President, Research Analyst, Life Sciences , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Axcella announced that its Phase 2a trial testing AXA-1125 in Long Covid has reached full enrollment. This placebo-controlled trial that enrolled 40 patients with data expected in late 3Q22.  It also announced that the Phase 2 trial for AXA1125 in NASH (non-alcoholic steateohepatitis) is continuing with data announcement expected in early 3Q222, and that the Phase 2 trial in Overt Hepatic Encephalopathy (OHE) has been terminated.

Phase 2a Trial In Long COVID Data Expected In Early 3Q22.  This placebo-controlled trial enrolled 40 patients with  Long COVID symptoms.  Long COVID is estimated to affect about 20% to 30% of the patients who were infected, recovered or were asymptomatic, then develop post-infectious symptoms of fatigue, muscle aches, and clouded thinking (“brain fog”).  AXA1125 has shown improvement in metabolic function that improve energetics and reduce symptoms….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Townsquare Media (TSQ) – Growth Appears To Be Accelerating

Tuesday, May 31, 2022

Townsquare Media (TSQ)
Growth Appears To Be Accelerating

Townsquare is a community-focused digital media and digital marketing solutions company with market leading local radio stations, principally focused outside the top 50 markets in the U.S. Our assets include a subscription digital marketing services business, Townsquare Interactive, providing website design, creation and hosting, search engine optimization, social media and online reputation management as well as other digital monthly services for approximately 26,800 SMBs; a robust digital advertising division, Townsquare IGNITE, a powerful combination of a) an owned and operated portfolio of more than 330 local news and entertainment websites and mobile apps along with a network of leading national music and entertainment brands, collecting valuable first party data, and b) a proprietary digital programmatic advertising technology stack with an in-house demand and data management platform; and a portfolio of 321 local terrestrial radio stations in 67 U.S. markets strategically situated outside the Top 50 markets in the United States. Our portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com and Loudwire.com.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Patrick McCann, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Non-deal road show highlights: This week Townsquare Media hosted a meeting for investors in St. Louis. Bill Wilson, CEO, accompanied by Stuart Rosenstein, CFO, and Claire Yenicay, EVP, highlighted the unique value proposition that the company brings to its local markets, in which its broadcasting business provides a launchpad for Townsquare’s digital media and digital marketing solutions businesses. Management expects to grow Digital revenue at 11.5% CAGR from 2021-2024. 

Small market sweet spot. Management noted that the company’s focus on markets outside the top 50 allows it to bring sophisticated digital marketing solutions to markets where it was very unsophisticated. Notably, since these markets are too small for larger operators, Townsquare has limited competition for its services….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Comstock Mining Inc. (LODE) – Tapping into Major Growth Opportunities

Tuesday, May 31, 2022

Comstock Mining Inc. (LODE)
Tapping into Major Growth Opportunities

Comstock (NYSE: LODE) innovates technologies that contribute to global decarbonization and circularity by efficiently converting under-utilized natural resources into renewable fuels and electrification products that contribute to balancing global uses and emissions of carbon. The Company intends to achieve exponential growth and extraordinary financial, natural, and social gains by building, owning, and operating a fleet of advanced carbon neutral extraction and refining facilities, by selling an array of complimentary process solutions and related services, and by licensing selected technologies to qualified strategic partners. To learn more, please visit www.comstock.inc.

Mark Reichman, Senior Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Annual General Meeting. Comstock hosted a well-attended annual general meeting on May 26 in Reno, Nevada. Management showcased its renewable energy businesses, including small-scale models of planned biorefinery and lithium-ion battery recycling facilities. Its renewable fuels division is advancing technologies to commercialize the conversion of woody biomass into advanced cellulosic fuels. Its lithium-ion battery (LIB) recycling business, LiNiCo, is commercializing a process to crush and separate lithium-ion batteries, extract lithium, nickel, cobalt, and graphite, and use the recovered metals to produce 99% pure cathode active precursor products.

Shareholder voting. Shareholders elected seven nominees to the Board, ratified the appointment of Comstock’s accounting firm, approved an advisory resolution for executive compensation, approved a change to the articles of incorporation, and approved the company’s 2022 equity incentive plan. With respect to the articles of incorporation, shareholders approved changing the corporate name to Comstock Inc. from Comstock Mining Inc. to better reflect the expanded scope of its business activities….

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

FDA Program May Help Investors Uncover Breakthrough Medical Technology

The FDA Breakthrough Devices Program may be a starting point for investors exploring the medical space. It’s designed to create a quicker path for medical devices that provide more effective treatment or diagnosis of life-threatening or irreversible conditions. There are significant benefits for the companies granted access to the program. Lists of devices after the companies have been granted a marketing authorization are available on the FDA website.

While new pharmaceuticals tend to grab headlines quicker than devices, investors looking for public companies, that may be uncorrelated to the pace of US economic growth or the financial markets, may visit the website and then research the companies on Channelchek.

Image Credit: US Food and Drug Administration (Flickr)

Benefits of the Breakthrough Devices Program

The purpose of the Breakthrough Devices Program is to provide patients and health care providers with timely access to novel medical devices by speeding up their development, assessment, and review. At the same time, it preserves the statutory standards for premarket approval, 510(k) clearance, and De Novo marketing authorization, consistent with the Agency’s mission to protect and promote public health.

Manufacturers have the opportunity to interact with the FDA’s experts through several different program options to efficiently address issues that present themselves during the FDA premarket review phase. This feedback from the FDA helps shorten the agreement phase. The company can also expect a prioritized review of its submission. This can have the effect of speeding the product to market with less cost and fewer problems.

How this Works

Pulling an example from the Channelchek library of videos from NobleCon18, we can use Perimeter Medical Imaging AI (PYNKF) to understand what a candidate looks like and how it may bring value to the patient, medical provider, and possibly investors.

Perimeter is an early-stage medical device company that expects its flagship product to address unmet cancer treatment needs. Initially, the device is expected to change the way breast cancer is treated and evaluated to improve outcomes and minimize the chance of recurrence or having to reoperate. In order to apply for the FDA designation, Perimeter’s device was indicated for breast cancer. However, the applications are expected to extend well beyond and into other major cancers in the $3.7 billion total market.

This FDA designation makes for a much more clear regulatory pathway. Perimeter meets the first guideline in that its product has unique technology (breakthrough) that is solving problems with a different method on a scalable platform. The procedures are expected to reduce the cost to patients, minimize the need for repeat surgery and be self-funding from the hospitals’ standpoint. This is because about 20 to 25% of cancer patients now need to return for a re-operation that costs approximately $16,000. Hospitals that adopt the Perimeter AI technology could serve patients better and stand to recover their costs while reducing overall patient costs on average.

Take-Away

There are many ways to uncover companies that are “on the move.” Reviewing those the FDA is likely to help along toward a full “go-ahead” is just one of them. For a more detailed look at Perimeter, their unique business model,  and technology, watch the 20-minute video below. For more on understanding the FDA Breakthrough Device Program in order to uncover companies that could change medicine, go to FDA.gov .

To evaluate small and growing companies, explore Channelchek beginning here.

Paul Hoffman

Managing Editor, Channelchek

Long-story-short-declining-oil-demand-expected-to-continue-into-2020

Will the Oil Slowdown Provoke a Renewable Energy Takeover? 

The Organization of the Petroleum Exporting Countries cut its demand forecast for the second consecutive month on Wednesday. The OPEC reduced the expected use for the remainder of the year to 1.02 million barrels per day, which is down 80,000 b/d from the August estimate. This decrease is attributed to the weaker-than-expected economic data in the first half of the year.

FEATURE: Artificial Intelligence | Gold-mining


Artificial Intelligence: Can an algorithm do what you do? AI will likely shape your future in more ways than you’d expect. More

Tribune
Publishing (TPCO)
Behind
The Curtain Of The Company’s Surprisingly Good 2019 Guidance. More

Townsquare Media (TSQ) What Will It Take For The Shares To Break Out? More

Investors are still waiting for a gold-mining merger wave. Small and midsize gold miners need to join forces to survive, investors say. More


Energy Fuels Inc. (UUUU), a leading producer of uranium and vanadium in the United States, issues letter to shareholders. More

Tribune Publishing (TPCO), a media company, reports fourth quarter and full year 2018 results. Company delivers year-over-year net income growth driven… More

Harte-Hanks (HHS), a data-driven, omni-channel marketing solutions and logistics company, beats Q4 earnings and revenue estimates. More

FEATURE: Gene Editing | Townsquare | KeyW | Salem | Energy Fuels | Gene Therapy…


CRISPR-Cas9: The Gene-Editing Tool That Could Fix Disease and Eradicate Cancer.
Is CRISPR-Cas9 the most influential scientific discovery of our generation? More 

Townsquare Media (TSQ) A Premium Valuation Appears Warranted. More

KeyW Holding Corporation (KEYW) Are needle moving contracts on the horizon. More

Salem Media Group (SALM) Why Investors Should Look Past The Soft Q1 Guidance. More

Energy Fuels (UUUU) Focusing On Vanadium Until Uranium Markets Improve; Trump To The Rescue? More


Making Profits, Saving Lives With Gene Therapy. After thirty years of development, gene therapy is seeing a surge of progress and profitability. Genprex Inc. (GNPX), Dyadic International Inc (DYAI), TrovaGene Inc. (TROV) and others… More 

TrovaGene, Inc. (TROV) , a clinical-stage, oncology therapeutics company, receives approximately $3.0 Million from exercise of warrants. More

Salem Media Group, Inc. (SALM), multimedia company specializing in Christian and conservative content, announces fourth quarter 2018 total revenue of $67.2 Million. More

NobleConXV Panel – Marketing Early-Stage Natural Resource Companies to Investors

Voices of Experience: Marketing Early-Stage Natural Resource Companies to Investors.

We would like to invite you to watch the Natural Resources panel from NobleConXV (
January, 2019), hosted by Noble Capital Market’s two senior natural resource equity analysts, Mark Reichman and Michael Heim. This panel focuses on the challenges early-stage exploration companies face when raising capital in the public market and how to overcome these challenges. Mr. Reichman and Mr. Heim question five executives of exploration stage mining and oil and gas companies on alternative ways to raise money, the importance of a strong management team/board, the future of commodity prices, government influence/risks, technical reports, and other topics.

Panelists

•             Dr. Keith Barron, Chairman and Chief Executive Officer, Aurania Resources Ltd. (TSXV: ARU)

•             Mr. Gregory Crowe, President, Chief Executive Officer
and Director, Silver One Resources Inc. (TSXV: SVE)

•             Mr. Henk van Alphen, Chief Executive Officer and Director, Wealth Minerals Ltd. (
TSXV : WML)

•             Mr. John Brda, President
and Chief Executive Officer, Torchlight Energy Resources, Inc. (NASDAQ: TRCH)

•             Mr. Douglas Bartole, President and CEO, InPlay Oil Corp. (TSXV: IPO)

 

Click here to watch the panel presentation

Today on Channelchek


Great Panther Completes Acquisition of Beadell.

 
Name Changed to Great Panther Mining Limited… More

Entravision Radio Stations Now Streaming on iHeartRadio. 

A diversified global media and advertising technology company serving Latino consumers, today announced that…

More

Big Pharma’s Hunt for New Drugs Is Pushing Up Cost of Deals.

Acquisitions of American biotech companies are surging, and so are the prices that buyers are willing to pay. More

Aurania’s Events During PDAC 2019. Aurania Resources Ltd. is attending the PDAC 2019 International Convention being held March 3 – March 6 in Toronto, Canada. More

Genco Shipping & Trading Limited Announces Fourth Quarter Financial Results. 
The largest U.S. headquartered drybulk shipowner focused on the transportation of major and minor bulk commodities globally, today reported its financial results for the three months and twelve months ended December 31, 2018. More 

How Will the Current M&A Frenzy in the Mining Industry Impact Investors? On February 25, Barrick Gold announced a hostile $17.8 billion bid for Newmont Mining… More

E. W. Scripps (SSP) Cutting through the noise. More